Epstein-Barr virus (EBV) infection of murine L cells expressing recombinant human EBV/C3d receptor
- PMID: 2848261
- PMCID: PMC282728
- DOI: 10.1073/pnas.85.23.9307
Epstein-Barr virus (EBV) infection of murine L cells expressing recombinant human EBV/C3d receptor
Abstract
The normal host range of Epstein-Barr virus (EBV) is limited to primate B lymphocytes and certain epithelial cells that express the C3d/EBV receptor [complement receptor 2 (CR2, CD21)]. In the present study, expansion of the tissue tropism of EBV has been accomplished by stably transfecting the murine fibroblast L cell line with pMT.CR2. neo.1, a eukaryotic expression vector promoting the transcription of a complementary DNA insert encoding human CR2. High CR2-expressing transfected L cells were selected by fluorescence-activated cell sorting. The recombinant CR2 was shown to have the same molecular weight as wild-type CR2 from Raji cells and to mediate the binding by the transfectants of particles bearing the iC3b and C3d fragments of the third component of complement. All CR2-expressing L cells, but not nontransfected controls, also bound EBV, as assessed by indirect immunofluorescence. After a 60-hr culture, approximately 0.5% of the CR2-expressing cells preincubated with EBV demonstrated immunofluorescent staining of EBV nuclear antigen with serum from a patient with nasopharyngeal carcinoma. No fluorescent staining of cells was seen with monoclonal antibodies to the early antigen complex or to gp350/220, indicating that the infection was predominantly latent. Infected cells cultured for up to 4 weeks remained EBV nuclear antigen-positive. The capacity of recombinant human CR2 to confer on murine L cells susceptibility to stable latent infection by EBV indicates that this receptor is a primary determinant of the tissue tropism of EBV and may facilitate studies of cell-specific factors that regulate the viral growth cycle.
Similar articles
-
Analysis of epitope expression and the functional repertoire of recombinant complement receptor 2 (CR2/CD21) in mouse and human cells.J Immunol. 1989 Aug 1;143(3):923-30. J Immunol. 1989. PMID: 2473114
-
Stable expression and function of EBV/C3d receptor following genomic transfection into murine fibroblast L cells.Eur J Immunol. 1990 Feb;20(2):409-16. doi: 10.1002/eji.1830200226. Eur J Immunol. 1990. PMID: 1690137
-
Epstein Barr virus/complement C3d receptor is an interferon alpha receptor.EMBO J. 1991 Apr;10(4):919-26. doi: 10.1002/j.1460-2075.1991.tb08025.x. EMBO J. 1991. PMID: 1849076 Free PMC article.
-
The Structure-Function Relationships of Complement Receptor Type 2 (CR2; CD21).Curr Protein Pept Sci. 2016;17(5):463-87. doi: 10.2174/1389203717666151201192124. Curr Protein Pept Sci. 2016. PMID: 26916158 Review.
-
CR2 complement receptor.J Invest Dermatol. 1990 Jun;94(6 Suppl):112S-117S. doi: 10.1111/1523-1747.ep12876069. J Invest Dermatol. 1990. PMID: 2161885 Review.
Cited by
-
Epstein-Barr virus tissue tropism: a major determinant of immunopathogenesis.Springer Semin Immunopathol. 1991;13(2):117-31. doi: 10.1007/BF00201463. Springer Semin Immunopathol. 1991. PMID: 1664981 Review. No abstract available.
-
Human immunodeficiency virus type 1-associated CD4 downmodulation.Adv Virus Res. 1994;44:203-66. doi: 10.1016/s0065-3527(08)60330-9. Adv Virus Res. 1994. PMID: 7817874 Free PMC article. Review.
-
Epstein-Barr virus (EBV)-negative B-lymphoma cell lines for clonal isolation and replication of EBV recombinants.J Virol. 1992 Aug;66(8):4972-81. doi: 10.1128/JVI.66.8.4972-4981.1992. J Virol. 1992. PMID: 1321281 Free PMC article.
-
Human poliovirus receptor gene expression and poliovirus tissue tropism in transgenic mice.J Virol. 1992 Jan;66(1):296-304. doi: 10.1128/JVI.66.1.296-304.1992. J Virol. 1992. PMID: 1370085 Free PMC article.
-
Epithelial cell polarization is a determinant in the infectious outcome of immunoglobulin A-mediated entry by Epstein-Barr virus.J Virol. 1997 Jan;71(1):519-26. doi: 10.1128/JVI.71.1.519-526.1997. J Virol. 1997. PMID: 8985380 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources